[Form 4] Limbach Holdings, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Limbach Holdings Chief Financial Officer Jayme L. Brooks reported open-market sales of company stock under a pre-arranged Rule 10b5-1 trading plan. On March 17, 2026, she sold a total of 9,910 shares of common stock in multiple transactions at weighted average prices ranging from $77.1047 to $81.4030 per share. Following these sales, Brooks directly holds 140,750 shares of Limbach common stock and has an additional 3,897 shares reported as indirectly held through the Brooks Family Trust, for which she disclaims beneficial ownership except to the extent of her pecuniary interest.
Positive
- None.
Negative
- None.
Insights
CFO’s sales are pre-planned under a 10b5-1 plan, with sizable holdings retained.
The filing shows Jayme L. Brooks, CFO of Limbach Holdings, executed open-market sales totaling 9,910 common shares on March 17, 2026. Sale prices were reported as weighted averages between $77.1047 and $81.4030 per share across several trade brackets.
A footnote states these transactions are part of a Rule 10b5-1 trading plan adopted on December 16, 2025, indicating they were pre-scheduled rather than opportunistic. After these sales, Brooks directly owns 140,750 shares and has 3,897 shares reported as indirectly held through the Brooks Family Trust, where she disclaims beneficial ownership beyond any pecuniary interest.
Because the trades are pre-planned and the CFO maintains a substantial remaining position, this filing typically reads as routine portfolio management rather than a clear shift in insider sentiment. Future company filings may give additional context on ongoing 10b5-1 activity.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,637 | $77.1047 | $203K |
| Sale | Common Stock | 4,167 | $78.0702 | $325K |
| Sale | Common Stock | 460 | $78.8042 | $36K |
| Sale | Common Stock | 1,546 | $80.2808 | $124K |
| Sale | Common Stock | 1,100 | $81.403 | $90K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- This transaction is part of a 10b5-1 plan adopted on December 16, 2025 by the reporting person. This transaction was executed in multiple trades at prices ranging from $76.57 to $77.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. This transaction was executed in multiple trades at prices ranging from $77.57 to $78.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. This transaction was executed in multiple trades at prices ranging from $78.57 to $79.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. This transaction was executed in multiple trades at prices ranging from $79.99 to $80.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. This transaction was executed in multiple trades at prices ranging from $81.16 to $81.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Shares held by the Brooks Family Trust. The reporting person and her spouse are trustees of the Brooks Family Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report will not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.